Rowan University

Rowan Digital Works
Faculty Scholarship for the College of Science &
Mathematics

College of Science & Mathematics

12-26-2019

Protein and Polysaccharide-Based Magnetic Composite Materials
for Medical Applications.
Elizabeth J Bealer
Kyril Kavetsky
Sierra Dutko
Samuel Lofland
Rowan University, lofland@rowan.edu

Xiao Hu
Rowan University, hu@rowan.edu

Follow this and additional works at: https://rdw.rowan.edu/csm_facpub
Part of the Materials Science and Engineering Commons, and the Physics Commons

Recommended Citation
Bealer, Elizabeth J.; Kavetsky, Kyril; Dutko, Sierra; Lofland, Samuel; Hu, Xiao. (2020). "Protein and
Polysaccharide-Based Magnetic Composite Materials for Medical Applications" Int. J. Mol. Sci. 21, no. 1:
186. https://doi.org/10.3390/ijms21010186

This Article is brought to you for free and open access by the College of Science & Mathematics at Rowan Digital
Works. It has been accepted for inclusion in Faculty Scholarship for the College of Science & Mathematics by an
authorized administrator of Rowan Digital Works.

International Journal of

Molecular Sciences
Review

Protein and Polysaccharide-Based Magnetic
Composite Materials for Medical Applications
Elizabeth J. Bealer 1,2 , Kyril Kavetsky 1 , Sierra Dutko 1 , Samuel Lofland 1
1

2
3

*

and Xiao Hu 1,2,3, *

Department of Physics and Astronomy, Rowan University, Glassboro, NJ 08028, USA;
bealere0@students.rowan.edu (E.J.B.); kavetskyk1@students.rowan.edu (K.K.);
dutkos7@students.rowan.edu (S.D.); lofland@rowan.edu (S.L.)
Department of Biomedical Engineering, Rowan University, Glassboro, NJ 08028, USA
Department of Molecular and Cellular Biosciences, Rowan University, Glassboro, NJ 08028, USA
Correspondence: hu@rowan.edu; Tel.: +1-856-256-4860; Fax: +1-856-256-4478

Received: 28 November 2019; Accepted: 23 December 2019; Published: 26 December 2019




Abstract: The combination of protein and polysaccharides with magnetic materials has been
implemented in biomedical applications for decades. Proteins such as silk, collagen, and elastin and
polysaccharides such as chitosan, cellulose, and alginate have been heavily used in composite
biomaterials. The wide diversity in the structure of the materials including their primary
monomer/amino acid sequences allow for tunable properties. Various types of these composites are
highly regarded due to their biocompatible, thermal, and mechanical properties while retaining their
biological characteristics. This review provides information on protein and polysaccharide materials
combined with magnetic elements in the biomedical space showcasing the materials used, fabrication
methods, and their subsequent applications in biomedical research.
Keywords: protein; polysaccharide; magnetic nanoparticles; biomaterials fabrication; nanomedicine;
drug delivery; tissue regeneration

1. Introduction
The use of magnetic materials in biomaterials and biomedicine has grown in popularity due to
their broadening applications in the field. Particle size, surface chemistry, and composition are some of
the tunable properties which allow for their integration into clinical drugs and devices [1,2]. Magnetic
nanoparticles (MNPs) are often favored due to their small size and controllable magnetization [3–7].
MNPs are anywhere from a few nanometers to about 100 nanometers in dimension [5,7,8] and often
have different properties compared to those of their bulk counterparts. In addition, magnetic materials
are easily functionalized with other biomaterials such as proteins and polysaccharides that increase
their biocompatibility and usefulness in applications [3,6,7,9]. These combinations of magnetic particles
with proteins and polysaccharides lead to new biomaterials that can be used in various applications.
One such example is tissue engineering where magnetic fields are used to promote the development of
new tissue in response to damage or loss [3,9–11]. Another example is drug delivery where products are
being tested in vivo with magnets to ultimately help release active drug therapies in patients [12–16].
The materials used for the aforementioned magnetic-based applications are diverse but have
similar immunogenic properties that make them ideal for used as biomaterials [17–20]. Protein-based
materials such as silk, keratin, and soy can be degraded in the body without adverse toxicity and have
physical properties that can be tuned to the user’s needs [17,21,22]. These materials are simple to
isolate and utilize enhancing their likelihood of being incorporated into various applications [23,24].
Polysaccharides (e.g., cellulose, chitosan, hyaluronan) are another group of materials that are
inexpensive natural products that provide biocompatibility and diversity in application [18,25].
Int. J. Mol. Sci. 2020, 21, 186; doi:10.3390/ijms21010186
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2.1. Protein Materials
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distinctive side chains vary between proteins [26]. Bonds between α-carbon atoms and the amino or
carbonyl group are singular and allow for freedom of rotation which permits the protein to fold in
many different ways, once again avoiding steric clash [27,28].
There are two major conformations of peptides that are sterically possible and most fully exploit
the hydrogen bonding available within the backbone: the α helix and the β sheet [26,29,30]. The α
helix is a rod-like structure that is formed from a tightly coiled backbone with outward extending side
chains. In β sheets, the polypeptide chain (β strand) is almost fully extended and the side chains of
adjacent amino acids alternate directions [27,28,31]. Linking β strands by hydrogen bonding creates the
β sheet. The linkage can be parallel, where the adjacent chains run in the same direction, or antiparallel,
where they run in the opposite direction [27,28]. Beta sheets can be relatively flat or take on a twisted
shape. The hydrogen bonds between the amine and carbonyl groups of the amino acids stabilize both
the α-helix and the β-sheet conformations [27,28].
The overall folding of proteins is complex and shows little to no signs of symmetry [32]. In most
scenarios, the polypeptide chain folds so that the hydrophobic side chains are buried within the
structure while the polar (hydrophilic) side chains are at the surface. In order for hydrophobic faces of
the secondary structures (α helices and β sheets) to be buried, the amine and carbonyl groups must be
hydrogen bonded. The stability of this overall shape is complemented by Van Der Waals interactions
between tightly packed hydrocarbon side chains [27,28].
Proteins that contain more than one polypeptide chain (subunit) display a fourth level of structural
organization that is based on the spatial arrangement of each subunit and the way in which they
interact with one another. Examples of these include dimers, trimers, and other quantities of identical
subunits within the protein [27,28].
2.1.1. Silk
Silk is a fibrous protein produced by animals from moths and butterflies to spiders and scorpions [33–36].
Its hydrophobic side chains, consisting mainly of glycine, alanine, and serine, allow for the formation of
β sheets within the protein and give silk its notoriously high tensile strength. The hydrophilic amino
acids in the structure of silk provide its elasticity [17,37,38]. Crystallinity of the β sheet can be tuned by
methanol treatments in order to modify its mechanical properties [39,40]. The most extensively studied
and utilized silk comes from the domestic silkworm, Bombyx mori, due to its large-scale production and its
biocompatibility. The cocoon of the Bombyx mori is made from naturally multi-layered silk fibroin fibers that
display a unique hierarchical structure which leads to its specific and singular strength and toughness [17].
Silk from the Nephila clavipes spider has also been popular in recent studies due to its ability to promote cell
adhesion and migration. Both silkworm and spider silks have proven to be promising biopolymers in the
biomaterials industry as tissue scaffolds [17].
2.1.2. Keratin
Keratins are cysteine-rich fibrous structural biopolymers that are the major components of hair,
feathers, nails and horns [41]. Two α helices wind around one another to form its superhelix structure;
one helix is designated type I, the other type II. There are two distinct groups of these proteins based on
the amino acid sequence: hard—short crystalline fibers embedded in a highly cross-linked elastomeric
matrix (hair and nails); and soft—cytoskeletal elements found in epithelial tissues [41,42]. Hard keratins
have large amounts of cysteines that interact through disulfide bonds which give them their enhanced
mechanical strength compared to that of soft keratins. Both groups have intrinsic biocompatibility,
biodegradability, mechanical durability, and natural abundance, making keratins very popular in
studies on their biomaterial applications [22,42,43].
2.1.3. Soy
Soy is a plant-based protein that is obtained from the soybean plant (Glycine max L. Merr.) [44].
This plant is comprised of a heterogeneous assortment of proteins, mainly globular storage proteins
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with two main subunits, conglycinin 7S and glycinin 11S [44]. These subunits both contain non-polar
amino acids: alanine, valine, and leucine; basic amino acids: lysine and arginine; and non-charged
polar amino acids: cysteine and glycine [17]. With the exception of the sulphur-containing amino acids,
soy protein mimics the amino acid patterns of high-quality animal protein sources [44,45]. Soy protein
is highly biodegradable and environmentally friendly, [46] and it is relatively easy to acquire soy due
to its abundance in nature. Soybean products such as soy protein isolate is used as an adhesive in
industrial applications [17]. Its biocompatibility allows for its use in tissue engineered scaffolds and as
a wound dressing [46].
2.1.4. Elastin
Elastin is an extracellular matrix protein that provides elasticity to tissues and organs such as
ligaments, lungs, blood vessels and arteries [47]. It consists of alternating hydrophobic and hydrophilic
domains, wherein the hydrophilic domains there are lysines scattered among alanines. This allows for
the cross-linkage of the molecules, which is further strengthened by the repetition of the hydrophobic
glycines, valines, and prolines [17]. Tropoelastin, the in vivo precursor to elastin, has been targeted for
its use in regenerative medicine. It crosslinks and has a direct impact of the structure and flexibility
on the protein [48]. Elastin protein has a resistance to enzymatic, chemical and physical degradation
which suggests long-term stability in biomedical or biomaterial applications [49,50]. In addition to
stability, its self-assembly behavior, elasticity, and biological activity make elastin-based biomaterials
greatly desirable [49–54].
2.1.5. Collagen and Gelatin
Collagen is the most abundant protein in animals, presenting in the skin and tendons, cartilage,
bone, and most internal organs. It is a fibrous and structural protein that provides structural and
mechanical support [49,51,55,56] and also aids in tissue functions such as scaffolding, morphogenesis,
and repair [57]. There are nearly 30 different types of collagen that have been identified and the three
main types that can be found in the human body are classified as Type I, II, or III. Every type of collagen
contains a repeating amino acid sequence where two amino acids are followed by a glycine. This allows
for a stable three-stranded α helical structure to form. Type I collagen is the most naturally abundant
and is used the most frequently in biomaterial studies [17]. Collagen is a good matrix material for
tissue engineering due to its ability to act as a natural substrate for cell attachment and allows for the
development of bioengineered tissue scaffolds [17,58]. Gelatin is derived from collagen hydrolysis and
is a biodegradable, bioresorbable material [59–61]. It is found as a mixture of peptides and type A
(acid hydrolysis) and type B (alkaline hydrolysis) are the two gelatins that are usually formulated from
native collagen [60]. These biomaterials are favorable due to their low cost and biocompatibility [59,62].
Recently the chemical and physical structure of gelatin has led to its use as a drug carrier agent and in
cell imaging applications [62].
2.2. Polysaccharide Materials
Polysaccharides are relatively complex carbohydrates that are formed from ten or more repeating
monosaccharides or disaccharides [63,64]. They are generally more stable than proteins since they are
usually not irreversibly denatured when heated [65]. Additionally, polysaccharides possess linear or
branched structure and can be monofunctional or polyfunctional. Other beneficial properties include
their high levels of chirality, water solubility or insolubility, and low toxicity [18,64]. There are storage
(starch and glycogen) and structural (cellulose and chitin) polysaccharides. Most polysaccharide-based
biomaterials are derived from structural polysaccharides, and their use in the biomedicine field
is expanding.
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2.2.1. Cellulose
Cellulose is a structural polysaccharide that is contained within the cell walls of plants and
animals [66,67]. Long polymer chains of glucose units connected by β-acetal linkages form its
crystalline structure, where β-glucose molecules join together to create a polymer [67]. Due to the
intramolecular hydrogen bonding within the joined glucose, cellulose can form very rigid fibers [68].
Different types of cellulose can be formed through unique methods, such as treating natural cellulose
(cellulose I) with sodium hydroxide, soaking it in cold (approximately −80 ◦ C) liquid anhydrous
ammonia, or soaking it in hot (approximately 200 ◦ C) glycerol. These methods transform cellulose I into
a crystalline matrix with a different set of properties. Of these, cellulose II (made by treating cellulose I
with sodium hydroxide) is the most thermodynamically stable [18]. The aforementioned properties
such as stability in temperature and mechanical properties allow for the fabrication of cellulose.
2.2.2. Chitin and Chitosan
Chitin is a long, linear chain of N-acetyl-d-glucosamine residues that naturally forms highly
crystalline ordered networks. The arrangement of chains in chitin can be designated as α, β, and γ
chitin. α-chitin is mostly found in arthropods and crustaceans, and has chains in a parallel arrangement;
β-chitin has an antiparallel arrangement; and γ-chitin is a combination of parallel and antiparallel
where out of every three chitin chains, two are parallel and one is antiparallel [18,69]. Chitin is
widely distributed among plants and animals and even found in the cell wall of fungi and algae.
Its strong intermolecular interactions through hydrogen bonding improve the rigidity of chitin and
limit its solubility.
Chitosan is also a linear polysaccharide composed of β-(1,4)-linked D-glucosamine and is
obtained by extensive deacetylation of chitin. Unlike chitin, chitosan is soluble in dilute aqueous
solutions. It has many properties that make it favorable to the biomedical community, such as its
bioactivity, antimicrobial activity, immunostimulation, chemotactic action, enzymatic biodegradability,
mucoadhesion and epithelial permeability [70,71].
2.2.3. Hyaluronan
Hyaluronan (hyaluronic acid) is a simple, water-soluble polysaccharide [72] whose structure is
an unbranched glycosaminoglycan chain that is formed from repeating disaccharide units containing
D-glucuronic acid and N-acetyl-d-glucosamine. It is expressed in the extracellular matrix, on the cell
surface, and inside the cell where it functions to maintain tissue hydration and lubrication [73]. It is
also found in soft connective tissues, joints, skin, eyes, and other tissue-derived organs. Hyaluronan is
important in homeostasis of plasma proteins and is thought to have a role in the mitotic process due to
its ability to help cells proliferate [74].
Hyaluronan has unique hydrophilic, rheological, and viscoelastic properties that contribute to its
significant role in biological processes and make it a good biomaterial [75]. The matrix of this polysaccharide
allows for cells to be in a hydrated environment and can increase their development [75,76]. Applications in
biomedicine to date include use as a serum for eye surgery and various other inflammatory conditions [74].
2.2.4. Alginate
Alginates are carboxylic polysaccharides that are produced almost exclusively in brown algae.
Their major components are the L-guluronate and D-mannuronate residues, whose ratio varies
depending on the natural source and form linear copolymers [77–79]. It is believed that only the
α-L-guluronate residues participate in intermolecular cross-linkage in order to form hydrogels; therefore,
the guluronate/mannuronate ratio, overall sequence, and length of the guluronate blocks are the driving
factors affecting the physical properties of alginate and its hydrogels [77–79]. They have a thickening
characteristic that allows them to increase the solvent viscosity upon dissolution, thus allowing for
physical stabilization within the solution. Their ionic change aptitude and gel-forming ability in the

Int. J. Mol. Sci. 2020, 21, 186
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW

6 of 25
6 of 25

Int. J. Mol. Sci.
20, x FOR PEERcounterions
REVIEW
6 of polyelectrolytes
25
presence
of2019,
multivalent
is a direct consequence of alginates being
and is
3. Magnetic
Properties
of Materials
for Biomedical
Applications
why
they
follow
the
usual
behavior
of
charged
polymers.
When
in
a
fibrous
or
film
form,
alginate
is
3. Magnetic Properties of Materials for Biomedical Applications
Int.as
J. Mol.
Sci. 2019, 20, x FOR
PEER REVIEW
6 of 25
used
hemostatic
materials
and wound dressings [72].
3.1.
Magnetism
of Materials
for Composites

3.1. Magnetism of Materials for Composites
Table 1 lists
typical magnetic
particles
used todayApplications
in various medical applications. The defining
3. Magnetic
Properties
of Materials
for Biomedical
3. Magnetic
Properties
of Materials
fortoday
Biomedical
Applications
Table 1 lists
magnetic
particles
used
in various
medical
applications.
The defining
characteristic
of typical
a magnetic
material
is the
magnetization
M, the
net magnetic
moment
per unit
characteristic
a Materials
magnetic
material
is the
magnetization
M, the
net magnetic
moment
per
unit
3.1. Magnetism
of
Composites
volume
and isofdependent
onfor
the
magnetic
field
H. The particular
response
depends
upon the
type
of
3.1.
Magnetism
of Materials
for
Composites
volume
andmaterial
is dependent
on thethere
magnetic
fielddiversity,
H. The particular
response
dependsantiferromagnetic,
upon the type of
magnetic
for which
is great
including
diamagnetic,
Table
1 lists typical
magnetic
particles
today in
various medical
applications.
The defining
magnetic
material
for which
there
is greatused
diversity,
including
diamagnetic,
antiferromagnetic,
ferromagnetic,
ferrimagnetic,
paramagnetic,
and superparamagnetic
phases. Since
most of the
characteristic
of
a
magnetic
material
is
the
magnetization
M,
the
net
magnetic
moment
per
unit
Table
1
lists
typical
magnetic
particles
used
today
in
various
medical
applications.
The defining
ferromagnetic,
paramagnetic,theand
superparamagnetic
Sincewill
most
of the
nanocompositesferrimagnetic,
rely upon maximizing
magnetic
forces, this phases.
discussion
focus
on
volume and is dependent
on maximizing
the magnetic the
fieldmagnetic
H. The particular
response
depends will
uponfocus
the type
of
nanocomposites
rely
upon
forces,
this
discussion
on
characteristic
of asuperparamagnetic
magnetic material
is the magnetization M, the net magnetic moment per unit
ferromagnetic and
materials.
magnetic material
for which there materials.
is great diversity, including diamagnetic, antiferromagnetic,
ferromagnetic
superparamagnetic
volume
and isand
dependent
the magnetic
field H. The particular
response
upon the type
ferromagnetic,
ferrimagnetic, on
paramagnetic,
and superparamagnetic
phases. Since
most ofdepends
the
Table 1. Common medical applications of magnetic particles used today.
nanocomposites
rely
upon
maximizing
the
magnetic
forces,
this
discussion
will
focus
on
of magnetic
material
for
which
there
is
great
diversity,
including
diamagnetic,
antiferromagnetic,
Table 1. Common medical applications of magnetic particles used today.
ferromagnetic and superparamagnetic materials.
Example Biomedical
ferromagnetic,
ferrimagnetic,
and
superparamagnetic
phases. Since most of the
Structure paramagnetic,
Composite
Materials
Example
Biomedical
Applications
Composite
Materials
Structure
nanocomposites rely
upon
maximizing
the
magnetic
forces,
this
discussion
will focus on ferromagnetic
Table 1. Common medical applications of magnetic particles usedApplications
today.
• Iron oxide particles
and superparamagnetic materials.
• Iron
oxide
particles
Example Biomedical
and
collagen
[10]
Structure
Composite
Materials
[10]
Applications
• and
Ironcollagen
oxides and
• Inclusions
in tissue
Table 1. Common medical
applications
particles
used today.
• Iron
oxides
and of magnetic
chitosan
[18]
•
Inclusions
inincrease
tissue
•chitosan
Iron oxide
particles
scaffolds
to
[18]
•
Heparin-coated
to increase
scaffolds
Structure
Composite
Example
Biomedical Applications
and collagen
[10] Materials
cell proliferation
[10]
Magnetite
• Heparin-coated
superparamagnetic
proliferation
[10]
Magnetite
•superparamagnetic
Iron oxides and
• cell
Drug
delivery and
(Fe3O4)
Inclusions
tissue
• oxide
Iron oxide particles and
collagen
[10]in and
iron
• •Drug
delivery
(Fe3O4)
chitosan [18]
tumor
targeting
iron
• oxide
Iron oxides and
[18]
•
Inclusions in tissue scaffolds to
scaffolds
to
increase
nanocomposites
[80]chitosan
tumor
targeting
• •Heparin-coated
methods
[18,80,83]. increase cell proliferation [10]
Heparin-coated
[80]superparamagnetic
cubic spinel
Magnetite
cell proliferation
[10]
Magnetite
• nanocomposites
Microcapsules
made
methods
[18,80,83].
superparamagnetic
cubic spinel
iron oxidemade
nanocomposites [80]
(Fe3(Fe
O4 )3O4)
• Microcapsules
• Drug delivery•andDrug delivery and tumor
from iron oxide
and
targeting methods [18,80,83].
oxide
Microcapsules
made from iron oxide
•ironiron
from
oxide
and
tumor targeting
alginate
and[81,82]
alginate [81,82]
nanocomposites
[80]
alginate [81,82]
methods [18,80,83].
cubic
cubicspinel
spinel
Microcapsules
made
• •Cobalt
ferrite and
silk • Hyperthermia
• Cobalt
ferrite
and and
silk • Hyperthermia
from iron
fibroin
[84] oxide
treatment
[84]
[81,82]
•alginate
Cobalt
ferrite
and silk
fibroin
[84] resonance
• fibroin
Cobalt
ferrite
alginate
• treatment
Magnetic
Cobalt
•
Hyperthermia treatment
•
Cobalt
ferrite
alginate
• Magnetic
resonance
• Cobalt
ferrite
alginate
Cobalt
composite
beads
[85]
imaging
ferrite
•
Magnetic resonance imaging
Cobalt ferrite
•
Cobalt
ferrite
and
silk
•
Hyperthermia
composite
beads
[85]
beads
[85] • imaging
ferrite
•
Magnetic separation
• composite
Zwitterionic
chitosan
Magnetic
separation
(CoFe
(CoFe
) 4)
2 O42O
•fibroin
Zwitterionic
chitosan shell
and
[84] chitosan
treatment
•• Magnetic
separation
• Zwitterionic
(CoFe2O4)
•
Drug delivery systems [87,88].
shell and
cobalt
Drug
delivery
cobalt
ferrite [86]
•shell
Cobalt
ferrite
Magnetic
resonance
Cobalt
delivery
and
cobaltalginate • •Drug
ferrite
[86]
systems
[87,88].
tetragonal
spinel
composite
imaging
ferrite
tetragonal spinel
[87,88].
ferrite
[86] beads [85] systems
Zwitterioniciron
chitosan • •Static
Magnetic
separation
(CoFe2O4)
magnetic
field
• •Neodymium
•
Static
magnetic
• Neodymium
iron
shell
and
cobalt
•
Drug
delivery
boron magnet with
altering bone field
•ferrite
Neodymium
iron boron
magnetbone
•
Static magnetic field altering
altering
boron
magnet
[86]
systems
[87,88].
tetragonal spinel
engineering
[91] bone engineering [91]
collagen
[89] with
with collagen [89]
Neodymum
Neodymum
engineering
[91]
collagen
[89]
• Neodymium
ironiron boron
• Enhancement
of
•Neodymium
Neodymium
magnet
•
Enhancement of cellular uptake of
Neodymum
iron
boron
Static
magnetic
iron
iron
boron
• •Enhancement
ofoffield
• •Neodymium
iron
boronwith
magnet
with
cellular uptake
chitosan
and the
inclusion
of
superparamagnetic nanoparticles
(Nd
Fe
B)
iron
boron
2
14
boron
magnet
with
altering
bone
(Nd2Fe14B)
cellular
uptake of in a delivery system [92].
boron
magnet
with
iron
oxide
particles [90]
chitosan
and
the
superparamagnetic
(Nd2Fe14B)
engineering
[91]
collagen
[89]
superparamagnetic
chitosan
the
Neodymum
inclusionand
of iron
nanoparticles in a
•inclusion
Neodymium
iron
•nanoparticles
Enhancement
Tetragonal
inof
a[92].
of iron
Tetragonal
iron boron
oxide particles
[90]
delivery system
boron
magnet
with
cellularsystem
uptake[92].
of
delivery
oxide
particles
[90]
(Nd2Fe14B)
chitosan and the
superparamagnetic
Forferromagnetic
ferromagnetic materials,
therethere
existsexists
a inclusion
spontaneous
magnetization
which exists
For
materials,
a spontaneous
magnetization
of iron
nanoparticles
in which
ain the exists in the absence
For of
ferromagnetic
materials,
exists
a spontaneous
magnetization
exists dinand
thef
Tetragonal
absence
an applied field.
This isthere
due to
the interaction
between
the spinsdelivery
ofwhich
neighboring
oxide
particles
[90]
system
[92].
of absence
an applied
This
isThis
due
to the
interaction
betweenthe
the spins
of neighboring
of an field.
applied
field.parallel
isto
due
toother
the
interaction
of neighboring
d and f d and f shell elements
shell elements
which align
each
in order tobetween
minimize thespins
electrostatic
energy. Because
which
align parallel
tovarious
each
other
order
toenergy
minimize
the
electrostatic
energy.
Because of competition
shell
elements
which
align
parallel
to eachinother
in the
order
to minimize
the electrostatic
energy.
Because
of competition
between
contributions
to
(anisotropy,
demagnetization,
Zeeman,
For ferromagnetic
materials,
there exists
a spontaneous
magnetization
which exists
in the
of
competition
between
various
contributions
to
the
energy
(anisotropy,
demagnetization,
Zeeman,
exchange),
there
are
local
energy
minima
which
generally
give
rise
to
hysteretic
M-H
curves
(Figure
between
contributions
thetoenergy
(anisotropy,
demagnetization,
Zeeman,
absencevarious
ofthere
an applied
field.
This
istodue
the generally
interaction
between
the
spins ofM-H
neighboring
d and f exchange), there are
exchange),
are local
energy
minima
give
rise tomagnetization
hysteretic
(Figure
2A,B).
At sufficiently
high
valuesgenerally
of H, Mwhich
approaches
theto
saturation
Mcurves
s. On reducing
local
energy
minima
which
give
rise
hysteretic
M-H
curves
(Figure
2A,B). At sufficiently
shell
elements
which
align
parallel
to
each
other
in
order
to
minimize
the
electrostatic
energy.
Because
2A,B).
At sufficiently
values of H,
M approaches
the saturation
magnetization
Msmagnetic
. On reducing
the field,
a remanent high
magnetization
persists
at zero applied
field and
only when the
field
of
competition
between
various
contributions
to
the
energy
(anisotropy,
demagnetization,
Zeeman,
high
values
of
H,
M
approaches
the
saturation
magnetization
M
.
On
reducing
the
field, the
a remanent
magnetization
persists atofzero
applied
fieldfield,
and only
field the field, a remanent
s the magnetic
opposes
magnetization
with a magnitude
Hc, the
coercive
does when
M change
sign.
exchange),
there are local with
energy
minima which
generally
givefield,
rise to
hysteretic
M-H
curves (Figure
opposes
the
magnetization
a
magnitude
of
H
c
,
the
coercive
does
M
change
sign.
magnetization
persists at zero applied field and only when the magnetic field opposes the magnetization
2A,B). At sufficiently high values of H, M approaches the saturation magnetization Ms. On reducing
withthea field,
magnitude
ofmagnetization
Hc , the coercive
M field
change
sign.when the magnetic field
a remanent
persistsfield,
at zerodoes
applied
and only
opposes
with
a magnitude
of Hcin
, the
coercive field,are
does
M change sign. of ferromagnetic materials;
Manythe
ofmagnetization
the magnetic
materials
used
composites
nanoparticles

however, their small size alters their magnetic properties from that of a bulk material as first discussed
by Néel [93]. The strong exchange interaction ensures that all spins are aligned with each other
but the magnetic anisotropy which gives rise to a preferred magnetic orientation is much weaker
and scales with the volume. When the particles are small enough, the thermal energy can be larger
than the anisotropy energy, and so the magnetization direction can wander. Such a system is called
superparamagnetic in that it acts like a paramagnet with noninteracting moments that align with H

Many of the magnetic materials used in composites are nanoparticles of ferromagnetic materials;
however, their small size alters their magnetic properties from that of a bulk material as first
discussed by Néel [93]. The strong exchange interaction ensures that all spins are aligned with each
other but the magnetic anisotropy which gives rise to a preferred magnetic orientation is much
weaker and scales with the volume. When the particles are small enough, the thermal energy can be
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larger than the anisotropy energy, and so the magnetization direction can wander. Such a system is
called superparamagnetic in that it acts like a paramagnet with noninteracting moments that align
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Figure 2. Schematic M-H curves of (A) A ferromagnet and (B) A superparamagnet; (C) A schematic
Figure 2. Schematic M-H curves of (A) A ferromagnet and (B) A superparamagnet; (C) A schematic
showing the demagnetization field in a spherical magnetic particle; (D) A schematic showing
showing the demagnetization field in a spherical magnetic particle; (D) A schematic showing a nona non-spherical magnetic particle can experience a magnetic torque even in a uniform field.
spherical magnetic particle can experience a magnetic torque even in a uniform field.

3.3. Forces and Torques on a Magnetic Sample
The magnetic energy density u is given by
u = −µ0 M·H

(4)

where µ0 is the permeability of vacuum. Since most particles are often approximately spherical or
spheroidal in shape, M is uniform throughout the particle if H is uniform, which is a reasonable
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approximation given that the gradient in H will have a much larger length scale than the submicron
scale of the particle. However, if the particle density is sufficiently large, this assumption may break
down due to dipolar fields from neighboring particles. Note that it is these dipolar fields which
generally contribute to the contrast enhancement in MRI by magnetic nanoparticles.
The force F on a given magnetic particle is given by negative the gradient of the potential energy
U, and if we assume that the density is small enough to ignore particle-particle interactions, then
F = −∇U = −µ0 V∇(M·H) ≈ µ0 V(M·∇)H

(5)

where V is the volume of the particle. The rightmost equation is true because ∇ × H = 0 since there are
no currents in the sample and because M is nearly uniform. In essence, the force is dependent on the
product of the M and the gradient in H although one needs to keep in mind that M itself is dependent
on H.
The magnetic torque density τ is given by
τ = µ0 M × H

(6)

If Happ is not along a principle axis of the object, then H and M are not parallel. Thus, magnetic
particles, even in a uniform field, can experience magnetic torques (Figure 2D). The magnetic torque has
a tendency to align the axis of the object with the smallest value of N to the magnetic field. This means
that spherical particles experience no torque while needles tend to orient with their primary axes
along H.
4. Fabrication Methods
4.1. Electrospinning
Table 2 summarizes advantages, parameters and applications of common magnetic material
fabrication methods based on proteins or polysaccharides. Electrospinning is a unique technique for
fabricating protein or polysaccharide-based magnetic materials. The process of electrospinning was
developed over one hundred years ago [95,96] and uses electrostatic forces to fabricate thin, nanoscale
fibers. A syringe pump, DC power supply, and ground collector are the primary components of
an electrospinning system (Figure 3) [96–101]. An electric potential of about 15~20 kV is needed to
maintain the process and is used in the two main conventional setups, vertical and horizontal [102].
The methods allow for different ways to collect the fibers, and the process itself is constantly being
updated to form fibers with varied orientations [103,104]. When the potential is applied, charge
induction will form what is known as a Taylor cone due to surface tension and electrical force [96,97].
When the electrical force exceeds the capillary pressure, fibers are drawn from a droplet that forms at
the top of a spinneret [96] and guided to the ground collector [105–107].
There are a number of factors that affect the fiber properties including the applied voltage,
temperature, and humidity, among others. Normally, electrospinning is done at room temperature,
and the resultant fibers often range in size from nanometers to microns [108–111]. Many types of fibers
can be produced such as polymer, composite, and synthetic which have led to electrospinning’s use in
a variety of fields [96,100,112,113].
Electrospun fibers with magnetic particles can be used in a variety of biomedical applications
that include tissue engineering [114,115] and drug delivery [116,117]. The success of the former
is because the nanofibers have high surface areas and therefore promote adhesion, proliferation,
and differentiation of cells [118,119]. Magnetic composite fibers have been synthesized by adding the
magnetic nanoparticles to the solution prior to processing the fibers [84]. Cobalt ferrite (CoFe2 O4 )
and magnetite (Fe3 O4 ) are commonly used magnetic nanoparticles, and their presence can alter the
physical properties of the fibers. [7,84,120,121].
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4.2. Film Casting

sheets or films can be produced via the film-casting method which is shown schematically in
4.2. Thin
Film Casting
Figure 4 [123–125]. This fabrication method is similar to electrospinning but differs in the direction
Thin sheets or films can be produced via the film-casting method which is shown schematically
that the film/sheet is drawn; this process stretches the film/sheet planarly. The molten solution in
in Figure 4 [123–125]. This fabrication method is similar to electrospinning but differs in the direction
a solvent is added to a flat-surfaced moving belt. The solution will spread out, cool, and dry on the
that the film/sheet is drawn; this process stretches the film/sheet planarly. The molten solution in a
belt, completely removing the solvent, and the dry film can then be removed [125]. This method
solvent is added to a flat-surfaced moving belt. The solution will spread out, cool, and dry on the
can produce films or sheets anywhere from about ten to a few thousand microns in thickness and
belt, completely removing the solvent, and the dry film can then be removed [125]. This method can
with large widths of up to a few hundred centimeters [124,126]. The speed of the film casting process
produce films or sheets anywhere from about ten to a few thousand microns in thickness and with
determines the ratio of the film thickness to its width and influences the physical properties [124].
large widths of up to a few hundred centimeters [124,126]. The speed of the film casting process
Film casting is often used to prepare nanocomposites [18]. with magnetic and polysaccharide-based
determines the ratio of the film thickness to its width and influences the physical properties [124].
materials having been used. Cellulose and chitosan are examples of polysaccharides that are used
Film casting is often used to prepare nanocomposites [18]. with magnetic and polysaccharidein film casting that have strong thermal stability [127,128]. Copper and gold particles that were
based materials having been used. Cellulose and chitosan are examples of polysaccharides that are
degassed have been used to produce films that possess magnetic properties [129]. Film casting has
used in film casting that have strong thermal stability [127,128]. Copper and gold particles that were
been used to modulate the antimicrobial properties, transparency, and thermally conductivity [18] of
degassed have been used to produce films that possess magnetic properties [129]. Film casting has
composite biomaterials.
been used to modulate the antimicrobial properties, transparency, and thermally conductivity [18] of
composite biomaterials.
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Figure 5. Schematic of the dip coating process showing the dipping, deposition of MNPs and evaporation
Figure 5. Schematic of the dip coating process showing the dipping, deposition of MNPs and
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Table 2. Advantages, parameters, and applications of the common protein or polysaccharide based
magnetic material fabrication methods. Source [14,18,84,108–111,118,119,124–128,132,134–137,139].
Composite Composition
•

Electrospinning

•
•
•

Chitosan and iron (II) and iron
(III) salts [122]
Chitin and iron chloride [143]
Cellulose acetate and silver
nanoparticles [144]
Cobalt ferrite, iron oxide and
silk fibroin [84]

Advantages
•
•
•
•

•
•
Film
Casting

•

Cellulose and chitosan with
gold nanoparticles [127,128]
Iron oxide and chitosan [145]

•
•

Dip
Coating

•
•
•

Silver and chitosan [137]
Iron oxide and collagen [146]
Heparin and
silver nanoparticles [18]

•
•
•

•

•
Infusion
Gyration

•

Lysozome protein and gold
nanoparticles [141]
DsRed-AuBP2-engineered
protein and
silver nanoparticles [147]

•
•
•

Fabrication of
nanosized particles
Large surface area
per mass
Small pore size
Tunable properties to
make rigid or
flexible fibers

Wide range of sizes (up
to a few
thousand microns)
Implementation
in manufacturing
Strong thermal stability

Adjustable thickness
Low cost
and convenience
Applicability for
irregularly
shaped objects
Automation

Flow control
Control of fiber size
Smooth,
well-aligned fibers

Parameters Affecting Process

•
•
•
•

Extruded solution
Applied voltage
Temperature
Humidity

•
•

Speed of process
Aspect ratio (distance
stretched over width)
Temperature

•

•
•
•
•
•

•

•
•

Applications

•
•

Tissue engineering
Promotion of
cell adhesion

•

Tissue
engineering constructs

Rates of condensation
and evaporation
Viscous drag
Surface tension
Viscosity and density of
coating material
Rate of withdrawal speed

•
•

Drug delivery
Antimicrobial surfaces

Concentration and
viscosity of
solution infused
Berry number
Speed of rotation

•
•

Magnetic actuation
Drug release
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5. Recent Magnetic Applications of Protein and Polysaccharide Materials
5.1. Tissue Regeneration
The applications of tissue engineering are expanding rapidly with great promise to create diverse
new tissues to treat various human conditions [3,9–11,148,149]. Magnetic nanoparticles and magnetic
cationic liposomes are currently being implemented in force-based tissue engineering [3,150,151]
while some tissue engineered constructs have been coated with a mixture of iron oxide particles and
collagen [10]. These studies demonstrate that magnetic scaffolds can help improve adhesion and
proliferation of various progenys of cells including bone marrow, bone, adipose, cartilage, and tendon
while remaining biocompatible [10,24,152].
The combination of chitosan and magnetic material was investigated by Sasaki et al. [153] to
show its abilities in the tissue engineering and regenerative medicine space (Figure 7A). The magnetic
nanoparticles were coated with chitosan and then added into cells. Cylindrical neodymium magnets
were used in this study. This enhanced the cell seeding in 3D scaffolds—A crucial issue in tissue
engineering. Cells often do not penetrate the tissue engineering construct and will remain superficial.
The magnetic force was able to push the seed cells deeper into the scaffolds. The degree of magnetic
force directly impacted how effective the invasion was. Cell-to-cell interactions and proliferation times
were improved with MNPs. The chitosan aided in the biocompatibility and biodegradability of the
MNPs as well. Cells were approximately 80% viable after the addition compared to 100% of the control.
This study showed promise and the hope for future designs that will lead to more cell infiltration in
tissue engineering.
Bock et al. [10] presented another application of magnetic scaffolds that used hydroxyapatite and
collagen (Figure 7B). There scaffolds were fabricated by dip-coating methods that added ferrofluids
with iron oxide particles. They concluded that their scaffolds should be further looked at for tissue
engineering applications. The proliferation of human bone marrow stem cells in vitro was achieved.
The magnetic nanoparticles were also able to be guided in the scaffold. This did not affect the scaffold,
which is essential to keep the porosity and shape of the construct [10].
Another study of collagen and MNPs was done by Panseri et al. [91] (Figure 7C). These scaffolds
were in vivo and had external magnets that helped to control regeneration. The orientation of the
scaffold was affected by the magnetics and the ECM was deposited similar to the orientation [89,91,154].
A NdFeB magnet was used and created a static magnetic field that augmented the bone tissue
engineering. The magnets were able to “fix” the scaffold and reduce the need for pin fixation that
is commonly used in bones. The overall goal in this study is to help with engineering of osseous
structures like metaphyseal bone [89].
Tissue engineering will be a large focus of protein and polysaccharide magnetic materials for
years to come. There are many applications that are still being investigated to promote proliferation
and adhesion of cells in vivo. The magnetic composites have shown to respond to magnetic fields
along with the ability to move cells and elements (e.g., growth factors) of the scaffold while the protein
and polysaccharide materials allow for better biocompatibility. This combination of tissue constructs
could ultimately lead to greater control over cell behavior and expansion.

Tissue engineering will be a large focus of protein and polysaccharide magnetic materials for
years to come. There are many applications that are still being investigated to promote proliferation
and adhesion of cells in vivo. The magnetic composites have shown to respond to magnetic fields
along with the ability to move cells and elements (e.g., growth factors) of the scaffold while the
protein and polysaccharide materials allow for better biocompatibility. This combination of tissue
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Studies have shown that protein and polysaccharide composite magnetic materials are advantageous
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produce targeting systems where the magnetic portion of the biomaterial can be guided to a specific
these materials to produce targeting systems where the magnetic portion of the biomaterial can be
site in vivo [12,15,159–161]. Drug-laden silk fibroin magnetic nanoparticles have been used in cancer
guided to a specific site in vivo [12,15,159–161]. Drug-laden silk fibroin magnetic nanoparticles have
research to access tumor sites [138,162]. Various polysaccharides such as heparin and chitosan have
been used in cancer research to access tumor sites [138,162]. Various polysaccharides such as heparin
been used with superparamagnetic iron oxides in the delivery of anticancer drugs and for tumor
and chitosan have been used with superparamagnetic iron oxides in the delivery of anticancer drugs
tagging capabilities [18,80,83].
and for tumor tagging capabilities [18,80,83].
Tian et al. [162] presented a novel cancer drug therapy with silk fibroin and magnetic nanoparticles
Tian et al. [162] presented a novel cancer drug therapy with silk fibroin and magnetic
(Figure 8A). Their process was to salt out silk fibroin with doxorubicin (DOX) and magnetite MNPs.
nanoparticles (Figure 8A). Their process was to salt out silk fibroin with doxorubicin (DOX) and
The combined particles were tested on a human breast adenocarcinoma cell line (MCF-7 cells) and its
magnetite MNPs. The combined particles were tested on a human breast adenocarcinoma cell line
resistant counterpart (MCF-7/ADR cells). An external magnetic field was applied to guide the drug to
(MCF-7 cells) and its resistant counterpart (MCF-7/ADR cells). An external magnetic field was
these resistant tumors in mice. According to their results, the tumors grew more extensively when
applied to guide the drug to these resistant tumors in mice. According to their results, the tumors
magnets were not attached to the drug-loaded silk fibroin while the silk fibroin helped to protect the
mice from the toxic effects of the chemotherapeutic drug. This study demonstrated in vivo tumor
targeting and drug delivery that could be effective against multidrug resistant forms of cancer using
the synergistic properties of MNPs and silk fibroin composite.
Another study on drug delivery was done by Javid et al. [80] using heparin-coated superparamagnetic
iron oxide nanocomposites (Figure 8B). They used DOX and paclitaxel (PTX) within the core of the
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Figure 8. Drug delivery uses of magnetic nanoparticles and protein/polysaccharide materials. (A) The
full drug delivery system used by Tian et al. that shows the combination of MNPs and silk protein.
(B) Images of a heparin-coated iron-oxide magnetic nanocomposite (Scale: 100 nm). (C) Composite of
MNPs and silk to deliver curcumin. (Reproduced with permission from Refs [80,162,163] (A) Copyright
ACS, 2017; (B) John Wiley and Sons, 2014; (C) RSC Publishing, 2014).
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5.3. Nanomedicine and Other Biomedical Applications
Magnetic resonance imaging (MRI) was one of the first implementations of magnetism into the biomedical
field and has since been expanded to include various aspects of medicine and nanomedicine [83,166].
Alginate has been introduced for use in MRI to aid in cell tracking and to act as a negative control contrast
agent [81–83,167]. Cellular therapies and labeling are now being implemented with MNPs in conjunction
with polysaccharides and proteins to improve medicine [168–175].
Shen et al. [81,82] have described a way to use alginate microcapsules for MRI (Figure 9B).
The microcapsules contain ferrofluid made from iron oxide and alginate and can be accessed without
surgery. The ferrofluid microcapsules can be seen with MRI because of a reduction in the T2 relaxation
time which increases the contrast, making it visible compared to the alginate alone. This can be used
for in vivo tracking of microcapsules to see the effects in the body in real time.
Magnetic nanoparticles have also been used in protein purification. The addition of MNPs into
the process allowed for high-resolution separations without the need for centrifugation, membrane
separation, or filtration. An example of this was shown by Chiang et al. [176] who used phosphopeptides
MNPs, and the tagged fusion proteins could be extracted from E. coli with high yields [151,176].
Targeting is the effort to locate evasive cancer cells which can then be tagged in vivo. This has
been another active area of investigation for magnetic nanoparticles and proteins/polysaccharides.
In a study done by Pulfer and Gallo [168] with magnetic aminodextran microspheres, they were
able to locate glioma tumors in rats (Figure 9C). The particles were able to remain in the brain for
extended time periods and the administration of the magnetic field could change the tissue distribution.
Daldrup-Link et al. [169,170] were able to label human hematopoietic progenitor cells with magnetic
polysaccharide nanoparticles that could change the relaxation rate and thus change the MRI imaging.
Signal intensities were improved with the addition of these contrast agents, providing another way to
locate cells in the body and tag them.
Cancer cell death and the shrinking of solid tumors have been enhanced with the use of magnetic
hyperthermia in recent studies [177–180]. The temperature is raised to 40–43 ◦ C and the effects of
chemotherapy are inceased with the induction of heat [179]. Cell viability and protein denaturation are
affected by even a raise in a half of degree [179]. Chang et al. [178] used uniform magnetic nanoparticles
of iron oxide and coated it with human-like collagen protein. An alternating magnetic field was able
to raise the temperature faster than non-collagen-coated nanoparticles. This application was able to
increase biocompatibility with a protein coating that could lead to further use of these composites for
magnetic hyperthermia in the future.
Nanoparticles will continue to be used in various biomedical applications. Though tissue
engineering and drug delivery are the most commonly used, targeting and MRI are some other
examples of the diverse power of MNPs with proteins and polysaccharides. It is expected that these
materials can be used in microgel assembly and mimic cell functions as the technology continues
to develop [3,181].
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6. Conclusions
The use of magnetic material with protein and polysaccharides has enhanced numerous biomedical
applications in the past decade. MNPs used in fibers and microspheres have been shown promise in
The use of magnetic material with protein and polysaccharides has enhanced numerous
tissue engineering, drug delivery, and nanomedicine. For example, the ability to guide proteins and
biomedical applications in the past decade. MNPs used in fibers and microspheres have been shown
polysaccharides by magnets can be an effective therapeutic to deliver cancer drugs. Multiple methods
promise in tissue engineering, drug delivery, and nanomedicine. For example, the ability to guide
allow for the integration of magnetic and biomedical materials. Proteins such as collagen, elastin,
proteins and polysaccharides by magnets can be an effective therapeutic to deliver cancer drugs.
keratin, soy, and silk serve as biocompatible, adaptable materials to be used in these aforementioned
Multiple methods allow for the integration of magnetic and biomedical materials. Proteins such as
applications. Polysaccharides including cellulose, chitin, chitosan, hyaluronan, and alginate offer
collagen, elastin, keratin, soy, and silk serve as biocompatible, adaptable materials to be used in these
further thermal stability and antimicrobial properties. These materials can also be augmented
aforementioned applications. Polysaccharides including cellulose, chitin, chitosan, hyaluronan, and
during fabrication to create layers or coatings with MNPs. Electrospinning, film-casting, dip-coating,
alginate offer further thermal stability and antimicrobial properties. These materials can also be
and infusion-gyration techniques have been successfully done in studies to create these composite
augmented during fabrication to create layers or coatings with MNPs. Electrospinning, film-casting,
materials. These methods can be tuned based on the materials used to change product elements
dip-coating, and infusion-gyration techniques have been successfully done in studies to create these
such as fiber thickness and coating concentration. Ultimately the introduction of the magnets and
composite materials. These methods can be tuned based on the materials used to change product
protein/polysaccharides allow for effective cell proliferation for tissue engineering, guidance and
elements such as fiber thickness and coating concentration. Ultimately the introduction of the
delivery of drugs, and tagging in imaging.
magnets and protein/polysaccharides allow for effective cell proliferation for tissue engineering,
guidance
and delivery
drugs,contributed
and tagging
in imaging.
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